🟢 ATAI Life Sciences BV is trading 6.1% up today as analysts maintain a Strong Buy consensus

ATAI Life Sciences BV is trading 6.1% up today at $4.08, extending a recent rebound from the high-$3 range as Wall Street analysts maintain a bullish outlook.

• The company currently carries a Strong Buy consensus from 7 Wall Street analysts with a $16 price target.
• The move suggests significant dip-buying interest following the recent pullback, even amid a mixed broader market backdrop.
• The $16 price target represents substantial upside potential from the current trading price.